List of insiders holdings for Olema Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 2024-12-04 19:55:22 | 9,575,296 251,676 | 9,826,972 | Form 4 |
| Paradigm Biocapital Advisors LP Paradigm BioCapital Advisors GP LLC Paradigm BioCapital International Fund Ltd. Asefaw Senai 10% Owner | 2024-11-14 16:34:56 | 5,503,600 0 | 5,503,600 | Form 13G |
| Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 2024-02-14 15:08:09 | 2,456,800 0 | 2,456,800 | Form 13G |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10% Owner | 2020-11-24 17:36:39 | 1,725,406 0 | 1,725,406 | Form 4 |
| Graham G. Walmsley Director | 2024-12-18 18:52:04 | 0 1,408,875 | 1,408,875 | Form 4/A |
| Harmon Cyrus Director | 2024-12-11 19:56:44 | 764,140 122,028 | 886,168 | Form 4 |
| Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 2024-12-11 19:56:03 | 598,333 167,677 | 766,010 | Form 4 |
| Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 2024-12-11 19:53:28 | 543,549 0 | 543,549 | Form 4 |
| MCCORMICK FRANK Director | 2020-11-23 16:33:24 | 191,113 84,260 | 275,373 | Form 4 |
| Zojwalla Naseem CHIEF MEDICAL OFFICER | 2024-12-17 19:29:41 | 242,349 0 | 242,349 | Form 4 |
| Bohen Sean PRESIDENT AND CEO | 2024-12-11 19:52:49 | 241,662 0 | 241,662 | Form 4 |
| Moriarty John B EVP, Ch. Legal Officer & Sec. | 2023-02-02 17:34:20 | 150,000 0 | 150,000 | Form 4 |
| Horn Kinney Chief Business Officer | 2023-02-02 17:30:22 | 150,000 0 | 150,000 | Form 4 |
| Kushner Peter J. CHIEF SCIENTIFIC OFFICER | 2022-02-03 19:12:25 | 61,750 0 | 61,750 | Form 4 |
| Hrustanovic Gorjan Director | 2024-06-18 17:00:17 | 23,000 0 | 23,000 | Form 4 |
| Larson Yi Director | 2024-06-18 17:00:21 | 23,000 0 | 23,000 | Form 4 |
| RAPPAPORT ANDREW Director | 2024-06-18 17:00:23 | 23,000 0 | 23,000 | Form 4 |
| Horning Sandra Director | 2024-06-18 17:00:25 | 23,000 0 | 23,000 | Form 4 |
| CLARK IAN T Director | 2024-06-18 17:00:16 | 23,000 0 | 23,000 | Form 4 |
| Garland J. Scott Director | 2024-06-18 17:00:15 | 23,000 0 | 23,000 | Form 4 |
| BUTITTA CYNTHIA M Director | 2024-06-18 17:00:10 | 23,000 0 | 23,000 | Form 4 |